213 related articles for article (PubMed ID: 11579505)
1. [CD7(+) acute myeloid leukemia (M0) associated with a mediastinal bulky mass lesion].
Yoshida K; Kusumoto S; Sugahara Y; Yagasaki F; Sakata T; Kawai N; Matsuda A; Suzuki T; Hirashima K; Kayano H; Bessho M
Rinsho Ketsueki; 2001 Aug; 42(8):644-9. PubMed ID: 11579505
[TBL] [Abstract][Full Text] [Related]
2. Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis.
Ogura K; Kimura F; Kobayashi S; Torikai H; Ikeda T; Sato K; Motoyoshi K
Leuk Res; 2006 Jun; 30(6):761-3. PubMed ID: 16140376
[TBL] [Abstract][Full Text] [Related]
3. [CD7 positive acute myelogenous leukemia exhibiting pleural involvement as an initial manifestation].
Ohe K; Okamura T; Arima F; Kamura T; Takamatsu Y; Murakawa M; Okamura S; Harada M; Niho Y
Rinsho Ketsueki; 1994 Jun; 35(6):552-6. PubMed ID: 7521403
[TBL] [Abstract][Full Text] [Related]
4. Trisomy 21 as a sole acquired abnormality in an adult Omani patient with CD7- and CD9-positive acute myeloid leukemia.
Udayakumar AM; Pathare AV; Muralitharan S; Alghzaly AA; Alkindi S; Raeburn JA
Arch Med Res; 2007 Oct; 38(7):797-802. PubMed ID: 17845902
[TBL] [Abstract][Full Text] [Related]
5. [Acute myeloblastic leukemia showing pronounced skin infiltration during administration of low-dose cytarabine and etoposide with granulocyte colony-stimulating factor].
Kawachi Y; Kuwajima Y; Nishihara T; Uchida T; Setsu K; Mori M; Ikeda K; Ikeda T; Sasaki K; Takahara J
Rinsho Ketsueki; 1997 Sep; 38(9):763-9. PubMed ID: 9364868
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia possibly producing thrombopoietic factor(s).
Fujita A; Matsuoka M; Shimonaka Y; Imai N; Asano S
Jpn J Clin Oncol; 1993 Dec; 23(6):366-72. PubMed ID: 7506802
[TBL] [Abstract][Full Text] [Related]
7. [Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy].
Kikuchi T; Miyata A; Fujii S; Kikuchi T
Rinsho Ketsueki; 2003 Nov; 44(11):1113-6. PubMed ID: 14689878
[TBL] [Abstract][Full Text] [Related]
8. Unrelated donor bone marrow transplantation for acute mixed lineage (myeloid and B-lymphoid lineage) leukemia in an adult with Down syndrome.
Takagi K; Yoshida A; Kinoshita K; Iwashima D; Imamaura S; Iwasaki H; Tsutani H; Ueda T
Ann Hematol; 2003 Apr; 82(4):236-40. PubMed ID: 12707727
[TBL] [Abstract][Full Text] [Related]
9. [Continuation of complete remission by oral administration of cytarabine ocfosfate in a patient with M0, who achieved remission by small doses of cytosine arabinoside with G-CSF].
Aoki S; Koyama S; Goto T; Takahashi H; Shibata A
Rinsho Ketsueki; 1995 Jan; 36(1):40-4. PubMed ID: 7536275
[TBL] [Abstract][Full Text] [Related]
10. [DBMP-85 was effective at diagnosis and LVP was effective at relapse in a case of acute mixed leukemia].
Endo M; Kanemaru M; Kubo Y; Kouda K; Sakurai T; Iizuka Y; Takeuchi J; Horikoshi A; Ohshima T
Rinsho Ketsueki; 1990 Mar; 31(3):320-4. PubMed ID: 2366335
[TBL] [Abstract][Full Text] [Related]
11. Mediastinal germ cell tumor with acute myeloid leukemia and growing teratoma syndrome.
Hirai Y; Yoshimasu T; Oura S; Okamura Y
Interact Cardiovasc Thorac Surg; 2011 Jan; 12(1):96-7. PubMed ID: 20940164
[TBL] [Abstract][Full Text] [Related]
12. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
13. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
14. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
15. [Therapy-related acute myeloid leukemia following double autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma].
Fujii H; Iwai T; Ueda Y; Nakagawa H
Rinsho Ketsueki; 2002 Jun; 43(6):482-7. PubMed ID: 12134706
[TBL] [Abstract][Full Text] [Related]
16. [Granulocytic sarcoma of the prostate presenting with urinary obstruction which progressed to acute myeloid leukemia].
Tsuboi K; Kawada H; Suzuki R; Murayama H; Ohmachi K; Nakamura N; Ogawa Y; Ando K
Rinsho Ketsueki; 2008 Nov; 49(11):1562-5. PubMed ID: 19047789
[TBL] [Abstract][Full Text] [Related]
17. [Successful selection of chemotherapy based on cell surface antigens in a patient with mixed phenotype acute leukemia].
Takasaki H; Tachibana T; Tanaka M; Maruta A; Ishigatsubo Y; Kanamoari H
Rinsho Ketsueki; 2010 May; 51(5):339-44. PubMed ID: 20534955
[TBL] [Abstract][Full Text] [Related]
18. Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
Brunet S; Esteve J; Berlanga J; Ribera JM; Bueno J; Martà JM; Bargay J; Guardia R; Juliá A; Granena A; Montserrat E; Sierra J;
Haematologica; 2004 Aug; 89(8):940-9. PubMed ID: 15339677
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].
Yamamoto K; Nagata K; Morita Y; Hamaguchi H
Rinsho Ketsueki; 2002 Jun; 43(6):488-92. PubMed ID: 12134707
[TBL] [Abstract][Full Text] [Related]
20. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
Yavuz S; Paydas S; Disel U; Sahin B
Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
